Why diet matters on GLP-1s GLP-1 medications and dual incretin medications (for example semaglutide and tirzepatide) can increase fullness and slow digestion, which can reduce cravings and portion sizes, but may also trigger GI side effects like nausea, vomiting, heartburn, bloating, diarrhea, and constipation, especially during dose increases
Kidney Int (2014) 86(5):10578
Parent(s) must be present for infusion
Quast, D., Schenker, N., Menge, B., Nauck, M., Kapitza, C., Meier, J
Nausea, vomiting, and diarrhea were typically the most common gastrointestinal adverse events, occurring in up to 48.4%, 23.2%, and 23.1% of participants, respectively, with events occurring predominantly during dose escalation and decreasing over time [10, 37, 43, 45,46,47]
Hold the vial up to light and look through it